logo

Breaking News

Share

The Allstate Corp. (ALL) said that it agreed to sell the property making up the majority of its campus in Northbrook, Illinois, to Dermody Properties for about $232 million. The sale is expected to close in 2022. Allstate noted that it is selling the property as employees have more choice about where...

Healthcare technology company Cue Health (HLTH) announced Monday it has completed an analysis of the SARS-CoV-2 B.1.1.529 variant, designated by the World Health Organization as Omicron. Using information from the GISAID database, Cue has determined its COVID-19 tests, which uses molecular (NAAT)...

iX Biopharma said that it will license to Seelos Therapeutics Inc (SEEL) its lead drug under development, Wafermine, a sublingual racemic ketamine wafer, and other products incorporating R- and S- enantiomers of ketamine utilising the WaferiX technology. As per the license agreement, iX Biopharma...

CANCOM said it presented vision 2025 and new sustainability strategy at Capital Markets Day. With Vision 2025, the company expects consolidated revenue of 2.5 billion euros, EBITDA of 275 million euros and Annual Recurring Revenue of 450 million euros. CANCOM is committed to achieving a net zero...

Ultragenyx Pharmaceutical Inc. (RARE) reported new long-term durability data from the phase 1/2 studies of DTX401 for Glycogen Storage Disease Type Ia and DTX301 for Ornithine Transcarbamylase deficiency. The additional longer-term phase 1/2 data with DTX401 for Glycogen Storage Disease Type Ia showed...

Walmart Inc. (WMT) announced Monday that Executive Vice President and Chief Financial Officer Brett Biggs will begin transitioning from Walmart during this upcoming year, after 22 years with the company, to begin a new chapter of opportunities in both the for-profit and non-profit sectors. Biggs will...

Athenex, Inc. (ATNX) said its Marketing Authorization Application for oral Paclitaxel for the treatment of advanced breast cancer has been validated by the United Kingdom's Medicines and Healthcare products Regulatory Agency for review. A single pivotal phase III study of oral Paclitaxel was the basis...

Molecular diagnostics company Co-Diagnostics, Inc. (CODX) reported Monday that none of the mutations in the heavily mutated SARS-CoV-2 variant recently discovered in Africa are predicted to interfere with any of the Company's suite of COVID-19 PCR diagnostic assays. Co-Diagnostics successfully assessed...

Viracta Therapeutics, Inc. (VIRX) announced the FDA has granted its all-oral combination product candidate, nanatinostat and valganciclovir (Nana-val), orphan drug designation for the treatment of Epstein Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified. Ivor Royston, CEO...

Code Pharma said that it plans to launch an Initial Public Offering and list its shares on the NASDAQ and Switzerland's SIX Swiss Exchange. Code Pharma is a global pharmaceutical company specializing in the development, manufacturing, and marketing of cost-effective treatments for infectious and...

Bristol Myers Squibb (BMY) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for deucravacitinib for the treatment of adults with moderate to...

BrainStorm Cell Therapeutics Inc. (BCLI) reported new analyses from the phase 3 trial of NurOwn in amyotrophic lateral sclerosis. It showed that although the phase 3 trial did not reach statistical significance on the primary and secondary endpoints, pre-specified and post hoc analyses leveraging different...

The European Commission has approved the combination of KEYTRUDA, Merck's anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, for the treatment of advanced or recurrent endometrial carcinoma in adults who have disease progression on or...

Lee Enterprises, Incorporated (LEE) issued a statement on the notice submitted by Alden Global Capital, LLC seeking to nominate three candidates to stand for election to Lee's Board. Lee Enterprises said, after completion of its review of Alden's purported notice, it will provide further information...

REIT American Tower Corp. (AMT) announced Monday the commencement of the tender offer by its wholly owned indirect subsidiary, Appleseed Merger Sub LLC, for all outstanding shares of the common stock of CoreSite Realty Corp. (COR) at a price of $170.00 per share in cash. The tender offer is being...

Follow RTT